<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f1 { font-family:ff6,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f3 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
#f4 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f5 { font-family:ff4,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f6 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page20.png">
<div class="txt" style="position:absolute; left:437px; top:54px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:56px; top:123px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">첫 바이오시밀러</span></div>
<div class="txt" style="position:absolute; left:56px; top:138px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽에서 순항 중</span></div>
<div class="txt" style="position:absolute; left:56px; top:377px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">램시마 못지않은 판매속도</span></div>
<div class="txt" style="position:absolute; left:189px; top:106px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,159,197,1);">2) 잘 팔리는 베네팔리</span></div>
<div class="txt" style="position:absolute; left:189px; top:124px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">동사는 자회사 바이오에피스를 통해 개발한 베네팔리(국내/미국 상품명 브렌시스)를 2016</span></div>
<div class="txt" style="position:absolute; left:189px; top:138px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">년 2월 유럽에 출시했다. 베네팔리는 Amgen이 개발한 류마티스 관절염 치료제 Enbrel의</span></div>
<div class="txt" style="position:absolute; left:189px; top:152px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">첫 번째 바이오시밀러이다. 베네팔리는 약가가 오리지널 대비 약 30% 저렴하며 Biogen이</span></div>
<div class="txt" style="position:absolute; left:189px; top:166px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽판매를 담당하고 있다. Enbrel은 2016년 기준 글로벌 매출 93억달러(약 10조원), 유</span></div>
<div class="txt" style="position:absolute; left:189px; top:180px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">럽매출 29억달러(약 3.3조원)를 기록한 전 세계 의약품 매출 순위 3위의 블록버스터 제품</span></div>
<div class="txt" style="position:absolute; left:189px; top:195px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">으로 2015년 2월 유럽에서 특허가 만료되면서 바이오시밀러가 출시될 수 있었다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:220px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;표 9&gt; Enbrel profile</span></div>
<div class="txt" style="position:absolute; left:189px; top:236px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">개발사</span></div>
<div class="txt" style="position:absolute; left:189px; top:247px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 판매사</span></div>
<div class="txt" style="position:absolute; left:189px; top:259px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽 판매사</span></div>
<div class="txt" style="position:absolute; left:189px; top:275px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">적응증</span></div>
<div class="txt" style="position:absolute; left:189px; top:292px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">성분명</span></div>
<div class="txt" style="position:absolute; left:189px; top:303px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">미국/유럽 특허 만료일</span></div>
<div class="txt" style="position:absolute; left:189px; top:315px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2016년 미국 매출</span></div>
<div class="txt" style="position:absolute; left:189px; top:326px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2016년 유럽 매출</span></div>
<div class="txt" style="position:absolute; left:189px; top:338px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2016년 매출 순위</span></div>
<div class="txt" style="position:absolute; left:279px; top:236px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Amgen</span></div>
<div class="txt" style="position:absolute; left:279px; top:247px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Amgen</span></div>
<div class="txt" style="position:absolute; left:279px; top:259px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Pfizer</span></div>
<div class="txt" style="position:absolute; left:279px; top:271px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">류마티스 관절염, 강직성 척추염, 소아 특발성 관절염, 건선, 건선성 관절염,</span></div>
<div class="txt" style="position:absolute; left:279px; top:280px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">방사선상으로 확인되지 않은 축성 척추관절염</span></div>
<div class="txt" style="position:absolute; left:279px; top:292px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Etanercept</span></div>
<div class="txt" style="position:absolute; left:279px; top:303px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2028 년 11 월, 2015 년 2 월</span></div>
<div class="txt" style="position:absolute; left:279px; top:315px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">57 억달러</span></div>
<div class="txt" style="position:absolute; left:279px; top:326px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">19 억달러</span></div>
<div class="txt" style="position:absolute; left:279px; top:338px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span></div>
<div class="txt" style="position:absolute; left:189px; top:352px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: Global Data, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:189px; top:377px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">베네팔리의 마케팅 파트너 Biogen에 따르면 제품 출시 첫해인 2016년 베네팔리의 유럽</span></div>
<div class="txt" style="position:absolute; left:189px; top:391px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">매출액은 1억 60만달러로 나타났다. 또한 2017년 1분기 매출액은 전년의 절반 이상인</span></div>
<div class="txt" style="position:absolute; left:189px; top:405px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">6,530만달러를 달성한 바 있다. 셀트리온이 Remicade 바이오시밀러 램시마를 유럽 시장</span></div>
<div class="txt" style="position:absolute; left:189px; top:419px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">에 최초로 출시했을 때와 비교해 보면 베네팔리의 매출 증가속도는 고무적이다. 2013년</span></div>
<div class="txt" style="position:absolute; left:189px; top:434px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽에서 판매승인을 받은 램시마가 본격적으로 판매된 것은 2015년 2월이었다. Pfizer에</span></div>
<div class="txt" style="position:absolute; left:189px; top:448px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">따르면 2015년 유럽 매출은 약 2,700만달러였으며 본격 출시 2년차인 2016년은 1억 7천</span></div>
<div class="txt" style="position:absolute; left:189px; top:462px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">만달러의 매출을 달성한 바 있다. 유럽 시장 내 점유율 역시 국가별로 평균 40%를 상회하</span></div>
<div class="txt" style="position:absolute; left:189px; top:476px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">고 있는 상황이다. 베네팔리 역시 현재 전 세계 16개국에서 판매되고 있으며 영국, 노르</span></div>
<div class="txt" style="position:absolute; left:189px; top:490px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">웨이 등 일부 국가에서는 40~60%의 점유율을 확보한 상황으로 베네팔리는 유럽 시장에</span></div>
<div class="txt" style="position:absolute; left:189px; top:505px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">서 빠르게 안착한 것으로 판단된다.</span></div>
<div class="txt" style="position:absolute; left:191px; top:532px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">[그림 20] 램시마와 베네팔리 유럽 내 매출 비교</span></div>
<div class="txt" style="position:absolute; left:213px; top:550px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(백만달러)</span></div>
<div class="txt" style="position:absolute; left:197px; top:559px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">180</span></div>
<div class="txt" style="position:absolute; left:197px; top:574px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">160</span></div>
<div class="txt" style="position:absolute; left:197px; top:589px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">140</span></div>
<div class="txt" style="position:absolute; left:197px; top:604px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">120</span></div>
<div class="txt" style="position:absolute; left:197px; top:618px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:201px; top:633px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">80</span></div>
<div class="txt" style="position:absolute; left:201px; top:648px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">60</span></div>
<div class="txt" style="position:absolute; left:201px; top:663px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">40</span></div>
<div class="txt" style="position:absolute; left:201px; top:677px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">20</span></div>
<div class="txt" style="position:absolute; left:205px; top:692px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:283px; top:559px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">램시마</span></div>
<div class="txt" style="position:absolute; left:269px; top:663px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">27</span></div>
<div class="txt" style="position:absolute; left:286px; top:700px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2015</span></div>
<div class="txt" style="position:absolute; left:333px; top:559px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">베네팔리</span></div>
<div class="txt" style="position:absolute; left:189px; top:718px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: Pfizer, 삼성바이오로직스, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:421px; top:557px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">171</span></div>
<div class="txt" style="position:absolute; left:465px; top:609px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">101</span></div>
<div class="txt" style="position:absolute; left:439px; top:700px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2016</span></div>
<div class="txt" style="position:absolute; left:522px; top:801px;"><span id="f4" style="font-size:10px;vertical-align:baseline;color:rgba(127,127,127,1);">19</span></div>
</body>
</html>
